Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Advanced Biomedical Research Year : 2016

Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis

Abstract

Although in the last two decades the World Health Organization (WHO) has introduced tuberculosis as "a threat to global", the vaccination with the Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is the only way for the prevention of this fatal infectious disease. Despite of the efficacy of BCG vaccine especially against infants' meningitis, it has still some limitations due to a variety of adverse effects. Many studies have evaluated the side effects of different strains of BCG vaccines in different countries. In Iran, some studies have been done so far to evaluate the adverse effects of 1173 P2 strain which is used for BCG vaccination. Each of these studies have used different standardization and sampling methods. This review will survey all studies that have been published about adverse effects of 1173 P2 strain of BCG vaccine in Iran using data mining methods.
Fichier principal
Vignette du fichier
Adverse effects of BCG vaccine 1173 P2 in Iran.pdf (550.96 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-02896898 , version 1 (11-07-2020)

Licence

Attribution - NonCommercial - ShareAlike

Identifiers

Cite

Saied Mostaan, Bahador Yazdanpanah, Rasool Moukhah, Hamidreza Hozouri, Manouchehr Rostami, et al.. Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis. Advanced Biomedical Research, 2016, 5 (1), pp.99. ⟨10.4103/2277-9175.183659⟩. ⟨pasteur-02896898⟩

Collections

RIIP RIIP_IRAN
34 View
94 Download

Altmetric

Share

Gmail Facebook X LinkedIn More